Inspire Medical Systems Inc [INSP] stock prices are up 5.61% to $199.32 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INSP shares have gain 13.72% over the last week, with a monthly amount glided 2.11%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on November 20, 2024, when BofA Securities upgraded its rating to a Buy and also boosted its price target to $255 from $220. Previously, BofA Securities downgraded its rating to Neutral on May 08, 2024, and dropped its price target to $225. On April 19, 2024, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $285 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $250 on March 19, 2024. Jefferies started tracking with a Buy rating for this stock on January 19, 2024, and assigned it a price target of $245. In a note dated January 02, 2024, Stifel downgraded an Hold rating on this stock but restated the target price of $210.
The stock price of Inspire Medical Systems Inc [INSP] has been fluctuating between $123.00 and $257.40 over the past year. Currently, Wall Street analysts expect the stock to reach $239.55 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $199.32 at the most recent close of the market. An investor can expect a potential return of 20.18% based on the average INSP price forecast.
Analyzing the INSP fundamentals
The Inspire Medical Systems Inc [NYSE:INSP] reported sales of 755.59M for trailing twelve months, representing a surge of 32.54%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.05 and Total Capital is 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 192.17 points at the first support level, and at 185.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 203.31, and for the 2nd resistance point, it is at 207.29.
Ratios To Look Out For
It’s worth pointing out that Inspire Medical Systems Inc [NYSE:INSP]’s Current Ratio is 7.84. Further, the Quick Ratio stands at 6.94, while the Cash Ratio is 1.99. Considering the valuation of this stock, the price to sales ratio is 8.01, the price to book ratio is 8.57 and price to earnings (TTM) ratio is 185.19.
Transactions by insiders
Recent insider trading involved Rondoni John, Chief Technology Officer, that happened on Nov 01 ’24 when 8703.0 shares were sold. Officer, JOHN RONDONI completed a deal on Nov 01 ’24 to buy 8703.0 shares. Meanwhile, Officer Ebeling Philip bought 5453.0 shares on Sep 11 ’24.
